A carregar...
JAK Inhibition as a New Treatment Strategy for Patients with COVID-19
After the advent of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the outbreak of coronavirus disease 2019 (COVID-19) commenced across the world. Understanding the Immunopathogenesis of COVID-19 is essential for interrupting viral infectivity and preventing aberrant immune responses...
Na minha lista:
| Publicado no: | Int Arch Allergy Immunol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7270061/ https://ncbi.nlm.nih.gov/pubmed/32392562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000508247 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|